Using statins, commonly used to prevent heart attacks, may also have the potential to stop blood clots from forming in the veins by 25 per cent, say researchers, including one of Indian-origin.
The condition, which affects millions globally, is one of the most preventable causes of hospital deaths, the study said.
The findings revealed that statins also known as cholesterol-lowering pills, reduces the threat of venous thromboembolism (VTE) by between 15 and 25 per cent.
"The research underscores a potential beneficial role of statin therapy on VTE in addition to its established role in cardiovascular disease prevention," said Kamlesh Khunti, Professor at the University of Leicester in the Britain.
Venous thromboembolism (VTE) is the formation of blood clots in the vein. When a clot forms in a deep vein, usually in the leg, it is called a deep vein thrombosis or DVT.
If that clot breaks loose and travels to the lungs, it is called a pulmonary embolism or PE.
Currently, statins are only approved for lipid lowering in the primary and secondary prevention of cardiovascular disease.
"But they have shown great promise beyond their established lipid-lowering effects and these include potential beneficial impact on multiple disease conditions," added Setor Kunutsor from the University of Bristol in Britian.
For the study, the team conducted an analysis of 36 studies involving more than 3.2 million people.
The study was published in The Lancet Haematology.
--IANS
rt/ksk/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
